Atipamezole
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Atipamezole (brand name Antisedan, Pfizer) is a synthetic α2 adrenergic receptor antagonist, indicated for the reversal of the sedative and analgesic effects of dexmedetomidine and medetomidine in dogs.[1] It has also been researched in humans as a potential anti-Parkinsonian drug.[2]
See also
- Detomidine, etc.
References
- ↑ Pfizer Animal Health ANTISEDAN Product Overview
- ↑ Pertovaara A, Haapalinna A, Sirviö J, Virtanen R (2005). “Pharmacological properties, central nervous system effects, and potential therapeutic applications of atipamezole, a selective alpha2-adrenoceptor antagonist”. CNS Drug Reviews. 11 (3): 273–88. doi:10.1111/j.1527-3458.2005.tb00047.x. PMID 16389294.
External links
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH